Copyright
©The Author(s) 2025.
World J Med Genet. Dec 2, 2025; 13(1): 112991
Published online Dec 2, 2025. doi: 10.5496/wjmg.v13.i1.112991
Published online Dec 2, 2025. doi: 10.5496/wjmg.v13.i1.112991
Table 1 Ocular manifestations of usher syndrome by subtype and gene involvement
| Usher subtype | Causative gene(s) | Onset of visual symptoms | Ocular findings | Imaging features |
| USH1 | MYO7A, CDH23, PCDH15 | Early childhood (1st decade) | Night blindness, peripheral vision loss, nystagmus | Bone-spicule pigmentation, attenuated vessels, waxy pallor of optic disc (OCT/FAF) |
| USH2 | USH2A, ADGRV1 | Adolescence (2nd decade) | Progressive peripheral visual field loss, nyctalopia | Mid-peripheral retinal degeneration, preserved macula until late (OCT/FAF) |
| USH3 | CLRN1 | Variable (2nd-4th decade) | Late-onset RP-like changes, high inter-individual variability | Variable OCT findings; mild-moderate outer retinal thinning |
| Atypical USH | CEP250, CEP78, HARS, ABHD12 | Adolescence-adulthood | RP-like symptoms without classical syndromic hearing loss | Macular atrophy, outer retinal loss, sometimes with foveal sparing or asymmetric loss |
- Citation: Zeppieri M, Musa M, Cordeiro MF, Gagliano C, D’Esposito F. Reevaluating Usher syndrome: Transitioning from traditional subtypes to precision diagnosis. World J Med Genet 2025; 13(1): 112991
- URL: https://www.wjgnet.com/2220-3184/full/v13/i1/112991.htm
- DOI: https://dx.doi.org/10.5496/wjmg.v13.i1.112991
